Bill Texts: LA HB403 | 2023 | Regular Session

Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]

Bill Drafts

RevisionDateFormatSourceView
ChapteredNot AvailPDFLinkView
EnrolledNot AvailPDFLinkView
EngrossedNot AvailPDFLinkView
IntroducedNot AvailPDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for Louisiana HB403

Supplemental Documents

TitleDescriptionDateFormatSourceView
AnalysisDigest of HB403 OriginalNot AvailPDFLinkView
AnalysisDigest of HB403 EngrossedNot AvailPDFLinkView

Social Comments on LA HB403

feedback